Navigation Links
Nano3D Biosciences Releases 96-well BioAssembler for 3D Cell Culture
Date:2/12/2013

Houston, TX (PRWEB) February 12, 2013

Nano3D BiosciencesTM (n3D), a company that specializes in three-dimensional (3D) cell culturing technology for the drug discovery, toxicology, and life science research markets, announces the release of its 24-well Bio-AssemblerTM.

"The release of our 96-well BioAssembler is another step forward in our ever increasing offering of 3D cell culture products using our proprietary magnetic levitation cell culture technology. The 96 well format will allow greater throughput and lend itself to laboratory automation technologies which will be of great benefit to high throughput drug screening and toxicity studies," said Chief Scientific Officer Dr. Glauco Souza.

The Bio-AssemblerTM promotes the development and growth of 3D cellular structures through magnetic levitation. It uses a proprietary nanoparticle-based assembly called “Nanoshuttle-PL” to deliver magnetic nanoparticles to the cells. Preparation time and cell manipulation are very similar to that of 2D cell culture or conventional cell culturing methods, with the end result allowing for a more accurate representation of in vivo tissue. The technology is compatible with any media, diagnostic technique or cell type. The company now offers 96, 24, 6 and single well formats. These products are available from MIDSCI in the US, Funakoshi in Japan, Novusci in the UK and directly from n3D.

n3D is proud to bring its groundbreaking solutions for 3D cell culturing to the drug discovery, toxicology, and life science research markets.

About n3D Biosciences
n3D is the award recipient of the Texas Emerging Technology Fund (TETF), National Science Foundation SBIR (Phase I and Phase II) awards, and the Goradia Innovation Prize. Located in Houston, TX this highly innovative biotech start-up is already making waves in the Biotechnology and Nanotechnology industry. The company has been featured in Nature Nanotechnology and MIT Technology Review (Bio-Assembling in 3-D with Magnetic Levitation - Technology Review) for its state-of-the-art 3D cell culturing technology.

Read the full story at http://www.prweb.com/releases/n3dbiosciences/newproduct/prweb10420438.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
2. The Law Firm of Levi & Korsinsky, LLP Launches an Investigation Into Possible Securities Laws Violations by Pacific Biosciences of California, Inc.
3. Coronado Biosciences to Present at the Oppenheimer 22nd Annual Healthcare Conference
4. Coronado Biosciences Announces Phase 1 Results of CNDO-109 in AML to be Presented at the American Society of Hematology
5. Sangamo BioSciences Announces Presentation of New Data from ZFP Therapeutic® Program in Hemophilia B at American Society for Hematology Meeting
6. Sangamo BioSciences Announces Presentation at J.P. Morgan Healthcare Conference
7. Sofie Biosciences Is Awarded a US Patent on a Family of Novel PET Probes for Use in Oncology and Immunology
8. Sangamo BioSciences Announces Fourth Quarter and Full Year 2011 Conference Call and Webcast
9. Neurocrine Biosciences to Present at the 14th Annual BIO CEO & Investor Conference
10. Ambit Biosciences to Present at Two Upcoming Investor Conferences
11. GeneLink Biosciences Completes Sale of GeneWize Life Sciences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... Feb. 16, 2017 Research and ... Biology: Global Markets" report to their offering. ... ... genes, biobrick parts, delivery plasmids, chassis organisms, synthetic cells, ... assembly, genome editing, bioinformatics and specialty media) and enabled ...
(Date:2/16/2017)... HOLLISTON, Mass. , Feb. 16, 2017   ... or the "Company"), a biotechnology company developing bioengineered organ ... the esophagus, bronchus and trachea, announced today the closing ... offering of 20,000,000 shares of common stock and warrants ... gross proceeds of $8.0 million. The offering was priced ...
(Date:2/16/2017)... , Feb. 16, 2017 UCHealth ( ... utilize LungDirect for pulmonary nodule patient management. In addition ... or a spot on the lung, UCHealth looks to ... manual data entry. Stephanie Brown, RN ... my nodule patients with an Excel spreadsheet, which was ...
(Date:2/16/2017)... 2017  Champions Oncology, Inc. (NASDAQ: CSBR ... of advanced technology solutions and products to personalize the ... addition of new cohorts of PDX models to their ... expand Champions, product line in hepatocellular cancer, breast cancer, ... and non-small cell lung cancer (including EGFR mutation; ALK/ROS1 ...
Breaking Biology Technology:
(Date:1/31/2017)... , Jan. 31, 2017  Spero Therapeutics, ... therapies for the treatment of bacterial infections, today ... of antibacterial candidates from Pro Bono Bio Ltd ... prevalence of multi-drug resistant forms of Gram-negative bacteria.  ... Anti Infectives Ltd, a PBB group company. ...
(Date:1/26/2017)... 2017  Crossmatch, a leading provider of security and ... at combatting fraud, waste and abuse in assistance operations ... Action on Disaster Relief conference in Panama ... agencies and foreign assistance organizations throughout Latin ... are a largely unacknowledged problem in the foreign assistance ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements of ... (IAM) lifecycle is comprised of a comprehensive set ... purpose of maintaining digital identities and providing a ... applications. There are significant number of programs opted ... to time by optimizing processes and changing policies. ...
Breaking Biology News(10 mins):